July 2013

Since the 1980s, the SynchroMed pump by Medtronic has been the leading intrathecal drug delivery system.  The most recent model, the SynchroMed II, is designed to be a programmable drug delivery system that stores and delivers pain medication into the intrathecal space via a sub-dermal catheter.  While the Synchromed II pump has been reported to

In recent news, there has been a massive mandatory recall for infusion pumps produced by the medical device company Medtronic.  These “SynchroMed” infusion pumps are implantable devices which release medication through a programmable administration system, allowing patients to undergo continuous medicative treatment without the need to orally or intravenously inject medication on a daily basis.  

Recently, Abbott Laboratories issued a recall for “four lots of Humira (adalimumab) Pen Psoriasis Starter Package with 4 single use prefilled pens of Humira for subcutaneous use only, 40 mg/0.8mL. The following lots and expiration dates (Exp) are being recalled because the some of the Humira Psoriasis Starter Packages may have been mispackaged with the

With over one tenth of all women with pelvic organ prolapse requiring surgery, researchers have begun to dedicate time and effort towards finding safe and effective methods to achieve higher satisfaction for patients.  Transvaginal mesh systems have emerged commercially over the past decades to try to reduce the failure rate of surgical pelvic organ prolapse

The use of transvaginal mesh (TVM) in repair of genital prolapse has become more popular in recent years, but with this has come a controversy over the safety of procedures involving TVM.  As many studies have shown that the use of transvaginal mesh can lead to serious complications for the patient, researches and designers have